Prof. Dr. med. Claudia Dorothea Baldus
Facts
Phone:
+49-431-500-22501
E-Mail:
claudia.baldus@uksh.de
Website:
Affiliations:
Clinic for Internal Medicine II, Hematology and Oncology / University Medical Center Schleswig-Holstein, Campus Kiel
Address:
Arnold-Heller-Str. 3, Bldg L
Curriculum vitae
Education/Training
| Since 10/2018 | Director of Medicine, Hematology and Oncology, Christian-Albrechts-University Kiel, Medical Center Schleswig-Holstein, Campus Kiel, Germany |
| 2009-2018 | Senior Attending Physician, Dept. of Hematology and Oncology, Charité, Berlin |
| 99-01,03-09 | Resident, Charité, University Medicine Berlin, Germany |
| 2000 | Dr. med. (Thesis in medicine) |
| 1992-1999 | Medical School, Universities of Homburg and Berlin, Germany |
Research Experience/Academic Appointments
| 2020 | Vice Dean of the medical Faculty of the CAU, Christian-Albrechts-University, Kiel |
| 2020 | Director of the University Cancer Center Schleswig-Holstein (UCCSH) |
| 2018 | Full Professor of Medicine, Hematology and Oncology, Christian-Albrechts-University, Kiel |
| 2011-2016 | Professor (W3) of Hematology, Mildred-Scheel Stiftungsprofessur, Charité Berlin |
| 2005-2011 | Max-Eder-Nachwuchsgruppenförderung, CBF Charité Berlin |
| 2001-2003 | Post-doctoral fellow, Human Cancer Genetics Program, OSU, Columbus, USA (Mildred-Scheel Stipendiat) |
Important Scientific Prizes/Functions
| 2017-2019 | Speaker Joint Research Project – DKTK Joint Funding project |
| 2015-2019 | Speaker Joint Research Project – German Cancer Aid, Translational Oncology |
| Since 2011 | Head of the trial research committee (GMALL Study Group) |
Project-related publications
P1, P3, P4, Z, INF, P6
IDH2 Clonal Hematopoiesis and IKAROS Loss Cooperate in a B-ALL Subtype after Lenalidomide Therapy for Multiple Myeloma
P1, P3, P4, Z
NGS-based IG/TR rearrangement profiling in acute lymphoblastic leukemia: age dependence of immunogenetic maturation
P2, P1, P3, INF
Mutational and transcriptional landscape of pediatric B-cell precursor lymphoblastic lymphoma.
P1, P3, P4, Z, INF
Developmental trajectories and cooperating genomic events define molecular subtypes of BCR::ABL1-positive ALL.
P1, P3, P4, INF, Z
The Gene Expression Classifier ALLCatchR Identifies B-cell Precursor ALL Subtypes and Underlying Developmental Trajectories Across Age
P1, P3, P4, INF
Insights into IGH clonal evolution in BCP-ALL: frequency, mechanisms, associations, and diagnostic implications
P1, P3, P4, INF, Z
IGH Rearrangement Evolution in Adult KMT2Arearranged B-cell Precursor ALL: Implications for Cell-of-origin and MRD Monitoring
P1, P3, P4, INF, Z
UBTF::ATXN7L3 gene fusion defines novel B cell precursor ALL subtype with CDX2 expression and need for intensified treatment
P1, P4, P6
In vivo inducible reverse genetics in patients’ tumors to identify individual therapeutic targets
P1, P3, P4, Z